Naghum Alfulaij to Administration, Oral
This is a "connection" page, showing publications Naghum Alfulaij has written about Administration, Oral.
Connection Strength
0.042
-
Horton JS, Shiraishi T, Alfulaij N, Small-Howard AL, Turner HC, Kurokawa T, Mori Y, Stokes AJ. "TRPV1 is a component of the atrial natriuretic signaling complex, and using orally delivered antagonists, presents a valid therapeutic target in the longitudinal reversal and treatment of cardiac hypertrophy and heart failure". Channels (Austin). 2019 12; 13(1):1-16.
Score: 0.042